- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01337765 | Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients | completed | Phase 1 | 29 | PfizerINDUSTRY | 5 | Oct 9, 2020 | clinicaltrials |
| NCT02055586 | FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents | completed | — | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 18, 2020 | clinicaltrials |
| NCT03008018 | Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours(HDAC6i) | completed | Phase 1 | 20 | Karus Therapeutics LimitedINDUSTRY | 1 | Aug 19, 2020 | clinicaltrials |
| NCT00002950 | Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 25 | Yale UniversityOTHER | 1 | Aug 17, 2020 | clinicaltrials |
| NCT00091299 | Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT00006083 | Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter | completed | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00070382 | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 14 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00390156 | Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors | completed | Phase 1 | 35 | University of California, San FranciscoOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT00750009 | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial | completed | Phase 3 | 583 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT00769951 | Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer | completed | — | 46 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT01866969 | Quality of Life in Caregivers of Hospitalized Older Patients With Cancer | completed | N/A | 211 | City of Hope Medical CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT01198145 | Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy | completed | Phase 3 | 87 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT01470365 | 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors | completed | Phase 1 | 24 | Fox Chase Cancer CenterOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT00081250 | Creatine in Treating Patients With Cancer-Associated Weight Loss | completed | Phase 3 | 300 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT00003891 | Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 9, 2020 | clinicaltrials |
| NCT01019187 | Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy | completed | Phase 2 | 226 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT00003890 | MG98 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | NCIC Clinical Trials GroupNETWORK | 2 | Apr 6, 2020 | clinicaltrials |
| NCT00006036 | Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 14 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 6, 2020 | clinicaltrials |
| NCT00003684 | Theophylline in Treating Cancer Patients With Shortness of Breath | completed | Phase 3 | 3 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00003687 | Treatment for Chronic Pain in Patients With Advanced Cancer | completed | Phase 3 | 87 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | completed | Phase 2 | 8 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT01892540 | PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer | completed | N/A | 43 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00645060 | Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT01488513 | ABC294640 in Treating Patients With Advanced Solid Tumors(ABC-101) | completed | Phase 1 | 22 | RedHill Biopharma LimitedINDUSTRY | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00036790 | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01326702 | Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors | completed | Phase 1 / Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00004872 | Endostatin in Treating Patients With Advanced Refractory Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00005794 | Perifosine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00023855 | PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00049712 | Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02146222 | VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors | completed | Phase 1 | 14 | University of Wisconsin, MadisonOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT00002677 | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors | completed | Phase 1 | 24 | University of Maryland, BaltimoreOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02822365 | Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors | completed | — | 2 | University of WashingtonOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT01898130 | Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy | completed | Phase 2 | 27 | Northwestern UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03081819 | A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer | completed | Phase 1 | 11 | Kyunghee University Medical CenterOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT00974168 | Spinal Cord Compression Re-Treat Study | completed | Phase 2 | 22 | Cancer Trials IrelandNETWORK | 1 | Jul 29, 2019 | clinicaltrials |
| NCT00026247 | Radiofrequency Ablation in Treating Patients With Bone Metastases(ACRIN-6661) | completed | N/A | 66 | American College of Radiology Imaging NetworkNETWORK | 1 | Jul 5, 2019 | clinicaltrials |
| NCT00874211 | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | completed | — | 3,571 | SWOG Cancer Research NetworkNETWORK | 3 | Jul 5, 2019 | clinicaltrials |
| NCT02324621 | Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Rutgers, The State University of New JerseyOTHER | 1 | May 22, 2019 | clinicaltrials |
| NCT03175497 | Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | Taizhou EOC Pharma Co., Ltd.INDUSTRY | 1 | May 13, 2019 | clinicaltrials |
| NCT01791088 | Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 56 | University of ChicagoOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT00909831 | Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment | completed | Phase 1 | 40 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02409108 | Perfusion-Induced Hyperthermia for Metastatic Carcinoma | completed | N/A | 4 | Jonathan KievOTHER | 1 | Apr 12, 2019 | clinicaltrials |
| NCT00390000 | Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 29 | Mayo ClinicOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT01537107 | Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 31 | Mayo ClinicOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT02717572 | 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT00002902 | Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 13, 2019 | clinicaltrials |
| NCT01713972 | Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors | completed | Phase 1 | 23 | Manisha ShahOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | completed | Phase 1 / Phase 2 | 59 | Northwestern UniversityOTHER | 1 | Feb 26, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Oct 9, 2020source: clinicaltrials